Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 8742079
Saccharide-containing protein conjugates and uses thereof
granted -
US 8741866
Compositions and methods for inhibiting expression of transthyretin
granted -
US 8741620
Human lysosomal proteins from plant cell culture
granted -
US 8741589
Monitoring two dimensions of diabetes pathogenesis
granted -
US 8741345
Modified release pharmaceutical compositions of dexlansoprazole
granted -
US 8741306
Kidney specific tumor vaccine directed against kidney tumor antigen G-250
granted -
US 8742075
Monoclonal antibodies against ANGPTL3
granted -
US 8740872
Magnetically-targeted treatment for cardiac disorders
granted -
US 8741649
Methods for enhancing genome stability and telomere elongation in embryonic stem cells
granted -
US 8741912
Deazapurines useful as inhibitors of Janus kinases
granted -
US 8741869
Oligodeoxynucleotide and its use to induce an immune response
granted -
US 8742121
Process for the preparation of small molecule inhibitors of MDM2 and intermediates used therein
granted -
US 8741937
Gamma glutamyl transpeptidase inhibitors and methods of use
granted -
US 8741922
Solid forms of N-(4-(7-azabicyclo[2.2,1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
granted -
US 8741880
Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
granted -
US 8741898
Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
granted -
US 8735407
Purine derivatives as A3 adenosine receptor-selective agonists
granted -
US 8735408
Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate
granted -
US 8735400
Compositions and methods for inhibition of the JAK pathway
granted -
US 8735401
Thienopyrimidine compounds and use thereof
granted -
US 8735418
Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases
granted -
US 8734830
Manufacturing method and apparatus of ultrafine particles having uniform particle size distribution
granted -
US 8735075
Cancer screening by detection of ultrastructural and molecular markers
granted -
US 8735095
High affinity human antibodies to human IL-4 receptor
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.